TTM
$258M
YoY change
-30.7%
5Y CAGR
-10.5%
Peak year (FY2023)
$457M
Cumulative EBITDA
$5.26B
EBITDA history chart for Bio-Techne (TECH) from 2016 to 2025
Latest: $217M
EBITDA growth chart for Bio-Techne (TECH) from 2016 to 2025
Latest: -30.7%
EBITDA history table for Bio-Techne (TECH) from 1989 to 2025
| FY2025 | $217M | -30.7% | -$96.3M | ||
| FY2024 | $313M | -31.5% | -$144M | ||
| FY2023 | $457M | +10.5% | +$43.3M | ||
| FY2022 | $414M | +65.6% | +$164M | ||
| FY2021 | $250M | -34.0% | -$129M | ||
| FY2020 | $378M | +78.6% | +$167M | ||
| FY2019 | $212M | +5.6% | +$11.3M | ||
| FY2018 | $201M | +11.8% | +$21.2M | ||
| FY2017 | $179M | -6.6% | -$12.6M | ||
| FY2016 | $192M | -0.5% | -$939K | ||
| FY2015 | $193M | +6.8% | +$12.4M | ||
| FY2014 | $181M | +4.4% | +$7.58M | ||
| FY2013 | $173M | -1.0% | -$1.68M | ||
| FY2012 | $175M | +0.6% | +$981K | ||
| FY2011 | $174M | +5.5% | +$9.11M | ||
| FY2010 | $165M | +3.8% | +$6.03M | ||
| FY2009 | $159M | +4.6% | +$7M | ||
| FY2008 | $152M | +10.6% | +$14.5M | ||
| FY2007 | $137M | +18.7% | +$21.6M | ||
| FY2006 | $115M | +11.2% | +$11.6M | ||
| FY2005 | $104M | +17.6% | +$15.6M | ||
| FY2004 | $88.3M | +19.2% | +$14.2M | ||
| FY2003 | $74.1M | +13.1% | +$8.56M | ||
| FY2002 | $65.5M | +11.9% | +$6.96M | ||
| FY2001 | $58.5M | +12.6% | +$6.55M | ||
| FY2000 | $52M | +40.5% | +$15M | ||
| FY1999 | $37M | +57.4% | +$13.5M | ||
| FY1998 | $23.5M | +33.5% | +$5.9M | ||
| FY1997 | $17.6M | +24.8% | +$3.5M | ||
| FY1996 | $14.1M | +27.0% | +$3M | ||
| FY1995 | $11.1M | +18.1% | +$1.7M | ||
| FY1994 | $9.4M | +14.6% | +$1.2M | ||
| FY1993 | $8.2M | +60.8% | +$3.1M | ||
| FY1992 | $5.1M | +88.9% | +$2.4M | ||
| FY1991 | $2.7M | +50.0% | +$900K | ||
| FY1990 | $1.8M | +125.0% | +$1M | ||
| FY1989 | $800K | — | — |
- FY2025$217M-30.7%
- FY2024$313M-31.5%
- FY2023$457M+10.5%
- FY2022$414M+65.6%
- FY2021$250M-34.0%
- FY2020$378M+78.6%
- FY2019$212M+5.6%
- FY2018$201M+11.8%
- FY2017$179M-6.6%
- FY2016$192M-0.5%
- FY2015$193M+6.8%
- FY2014$181M+4.4%
- FY2013$173M-1.0%
- FY2012$175M+0.6%
- FY2011$174M+5.5%
- FY2010$165M+3.8%
- FY2009$159M+4.6%
- FY2008$152M+10.6%
- FY2007$137M+18.7%
- FY2006$115M+11.2%
- FY2005$104M+17.6%
- FY2004$88.3M+19.2%
- FY2003$74.1M+13.1%
- FY2002$65.5M+11.9%
- FY2001$58.5M+12.6%
- FY2000$52M+40.5%
- FY1999$37M+57.4%
- FY1998$23.5M+33.5%
- FY1997$17.6M+24.8%
- FY1996$14.1M+27.0%
- FY1995$11.1M+18.1%
- FY1994$9.4M+14.6%
- FY1993$8.2M+60.8%
- FY1992$5.1M+88.9%
- FY1991$2.7M+50.0%
- FY1990$1.8M+125.0%
- FY1989$800K—
EBITDA values are taken from Bio-Techne's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's current EBITDA (TTM) is $258M. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Bio-Techne (TECH) EBITDA is $217M – plunged 30.7% year-over-year.
Bio-Techne EBITDA compound annual growth for the 2020–2025 (5 years) window is -10.5%, with a net decline across the window.
Bio-Techne EBITDA plunged from $457M in 2023 to $217M in 2025, a 52.6% drawdown.
The highest annual EBITDA of $457M was reported in 2023. The lowest in the available history was $800K in 1989.
Bio-Techne EBITDA by Year
Bio-Techne EBITDA 2025: $217M
Bio-Techne EBITDA in 2025 was $217M, plunged 30.7% below 2024.
Bio-Techne EBITDA 2024: $313M
2024's EBITDA for Bio-Techne came in at $313M, plunged 31.5% below 2023.
Bio-Techne EBITDA 2023: $457M
Bio-Techne posted EBITDA of $457M in 2023, grew 10.5% from 2022. This figure represents the highest annual value in the available history.
Bio-Techne EBITDA 2022: $414M
In 2022, Bio-Techne reported EBITDA of $414M, surged 65.6% from 2021.
Bio-Techne EBITDA 2021: $250M
Bio-Techne EBITDA in 2021 was $250M.
See more financial history for Bio-Techne (TECH).
Sector peers by EBITDA
Healthcare peers of Bio-Techne (TECH), ranked by their latest EBITDA
| $41.1B | |
| $28.3B | |
| $27.9B | |
| $24.4B | |
| $23.1B | |
| $17.6B | |
| $16.9B | |
| $11.5B |
- $41.1B
- $28.3B
- $27.9B
- $24.4B
- $23.1B
- $17.6B
- $16.9B
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.23% TTM
- Dividend Profile0.44% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.